← Back to directory

Ylermi Soini

Researcher Next ID · RN-039399

Researcher · Biochemistry, Genetics and Molecular Biology

University of Eastern Finland

Joensuu, Finland

Accepting doctoral researchersFunding unknown
Works count
358
Citation count
16,432
H-index
66
i10-index
262

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Neuroscience
Glutathione Transferases and Polymorphisms
Redox biology and oxidative stress
Barrier Structure and Function Studies
Sulfur Compounds in Biology
Cancer-related Molecular Pathways

Publications

  • Reactive Oxygen Species‐Mediated Mechanisms of Action of Targeted Cancer Therapy

    Oxidative Medicine and Cellular Longevity · 2017 · https://doi.org/10.1155/2017/1485283

  • For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality

    Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2015 · https://doi.org/10.1007/s00428-015-1758-z

  • miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer

    Oncogene · 2014 · https://doi.org/10.1038/onc.2014.267

  • Depth of invasion, tumor budding, and worst pattern of invasion: Prognostic indicators in early‐stage oral tongue cancer

    Head & Neck · 2013 · https://doi.org/10.1002/hed.23380

  • Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

    Human Molecular Genetics · 2011 · https://doi.org/10.1093/hmg/ddr228

  • Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (I)

    Oral Oncology · 2010 · https://doi.org/10.1016/j.oraloncology.2010.06.006

  • Carbonic anhydrase IX in oligodendroglial brain tumors

    BMC Cancer · 2008 · https://doi.org/10.1186/1471-2407-8-1

  • A recurrent mutation in PALB2 in Finnish cancer families

    Nature · 2007 · https://doi.org/10.1038/nature05609

  • Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies

    Apmis · 2007 · https://doi.org/10.1111/j.1600-0463.2007.apm_514.x

  • Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours

    Histopathology · 2005 · https://doi.org/10.1111/j.1365-2559.2005.02127.x

  • Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

    Annals of Oncology · 2005 · https://doi.org/10.1093/annonc/mdi064

  • Peroxiredoxins, a novel protein family in lung cancer

    International Journal of Cancer · 2004 · https://doi.org/10.1002/ijc.20294

  • Peroxiredoxins in breast carcinoma.

    PubMed · 2003

  • Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma

    The Journal of Pathology · 2002 · https://doi.org/10.1002/path.1042

  • Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.

    PubMed · 2001

  • A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma.

    PubMed · 2000

  • Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.

    PubMed · 2000

  • Prognostic factors in tongue cancer – relative importance of demographic, clinical and histopathological factors

    British Journal of Cancer · 2000 · https://doi.org/10.1054/bjoc.2000.1323

Current projects

    No projects listed.